Clinical Trials Logo

Clinical Trial Summary

This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian epithelial carcinoma


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05856643
Study type Interventional
Source Shantou University Medical College
Contact ChongZhu Li, PhD
Phone 13923998618
Email czli2013@163.com
Status Not yet recruiting
Phase Early Phase 1
Start date June 1, 2023
Completion date December 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT01536743 - A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression Phase 2
Recruiting NCT05763199 - Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy Phase 2
Recruiting NCT04794322 - Developing a Test for the Detection of Ovarian Cancer